High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria

Acta Tropica

Volumn 119, Issue 1, 2011, Pages 11-13

  Wélé, Mamadou ^a   Djimdé, Abdoulaye A ^a   Guindo, Aldiouma ^a   Beavogui, Abdoul H ^a   Traoré, Isaac Z ^a   Sadou, Aboubacar ^a   Blaise, Dackouo ^a   Diallo, Dapa A ^a   Wellems, Thomas E ^b   Doumbo, Ogobara K ^a  

^a UNIVERSITY OF BAMAKO   (Mali)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Drug resistance; Non severe malaria; PfCRT 76T; Severe malaria

Indexed keywords

CHLOROQUINE; QUININE;

DISEASE PREVALENCE; DRUG RESISTANCE; HEMOGLOBIN; MALARIA; MUTATION; VILLAGE;

AGE; ALLELE; ARTICLE; BACTERIAL GENE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MALI; PFCRT GENE; PREVALENCE;

ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DNA, PROTOZOAN; DRUG RESISTANCE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MALI; MEMBRANE TRANSPORT PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; PREVALENCE; PROTOZOAN PROTEINS; SEVERITY OF ILLNESS INDEX;

MALI;

MALIA;

EID: 79957604428     PISSN: 0001706X     EISSN: 0001706X     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.01.002     Document Type: Article

References (17)

1. Cooper R.A., Hartwig C.L., Ferdig M.T. PfCRT is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta Trop. 2005, 94:170-180.
2. Cravo P., Culleton R., Hunt P., Walliker D., Mackinnon M.J. Antimalarial drugs clear resistant parasites from partially immune hosts. Antimicrob. Agents Chemother. 2001, 45:2897-2901.
3. Djimde A., Doumbo O.K., Cortese J.F., Kayentao K., Doumbo S., Diourte Y., Dicko A., Su X.Z., Nomura T., Fidock D.A., Wellems T.E., Plowe C.V., Coulibaly D. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 2001, 344:257-263.
4. Falk N., Kaestli M., Qi W., Ott M., Baea K., Cortes A., Beck H.P. Analysis of Plasmodium falciparum var genes expressed in children from Papua New Guinea. J. Infect. Dis. 2009, 200:347-356.
5. Fowler E.V., Chavchich M., Chen N., Peters J.M., Kyle D.E., Gatton M.L., Cheng Q. Physical linkage to drug resistance genes results in conservation of var genes among West Pacific Plasmodium falciparum isolates. J. Infect. Dis. 2006, 194:939-948.
6. Giha H.A., Elbashir M.I., Elbasit I.E., Elgadir T.M., ElGhazali G.E., Mackinnon M.J., Babiker H.A. Drug resistance-virulence relationship in Plasmodium falciparum causing severe malaria in an area of seasonal and unstable transmission. Acta Trop. 2006, 97:181-187.
7. Guindo A., Fairhurst R.M., Doumbo O.K., Wellems T.E., Diallo D.A. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med. 2007, 4:e66.
8. Laufer M.K., Thesing P.C., Eddington N.D., Masonga R., Dzinjalamala F.K., Takala S.L., Taylor T.E., Plowe C.V. Return of chloroquine antimalarial efficacy in Malawi. N. Engl. J. Med. 2006, 355:1959-1966.
9. Mayengue P.I., Kalmbach Y., Issifou S., Kremsner P.G., Ntoumi F. No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria. Parasitol. Res. 2007, 100:487-493.
10. Meerman L., Ord R., Bousema J.T., van N.M., Osman E., Hallett R., Pinder M., Walraven G., Sutherland C.J. Carriage of chloroquine-resistant parasites and delay of effective treatment increase the risk of severe malaria in Gambian children. J. Infect. Dis. 2005, 192:1651-1657.
11. Olumese P.E., Amodu O.K., Bjorkman A., Adeyemo A.A., Gbadegesin R.A., Walker O. Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:418-420.
12. Ranjit M.R., Das A., Chhotray G.P., Das B.P., Das B.N., Acharya A.S. The PfCRT (K76T) point mutation favours clone multiplicity and disease severity in Plasmodium falciparum infection. Trop. Med. Int. Health 2004, 9:857-861.
13. Tekete M., Djimde A.A., Beavogui A.H., Maiga H., Sagara I., Fofana B., Ouologuem D., Dama S., Kone A., Dembele D., Wele M., Dicko A., Doumbo O.K. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali. Malariol. J. 2009, 8:34.
14. Trape J.F., Pison G., Preziosi M.P., Enel C., Desgrees du L.A., Delaunay V., Samb B., Lagarde E., Molez J.F., Simondon F. Impact of chloroquine resistance on malaria mortality. C R Acad. Sci. III 1998, 321:689-697.
15. Wellems T.E., Plowe C.V. Chloroquine-resistant malaria. J. Infect. Dis. 2001, 184:770-776.
16. World Health Organization Framework for developing, implementing and updating antimalarial treatment policy in Africa: a guide for country malaria control programme managers. Malaria programme 2000, African Regional Office of WHO, Harare.
17. World Health Organization Communicable diseases cluster. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 2000, 94(Suppl. 1):S1-90.